Ellerson Group »

iShares Dow Jones US Pharm Indx shares owned by Ellerson Group

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Ellerson Group from 13F filings

Historical chart of Ellerson Group investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Ellerson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Ellerson Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $222k 2.6k 84.83

More positions owned by Ellerson Group

NVIDIA Corporation (NVDA)
Palantir Technologies Cl A (PLTR)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Regeneron Pharmaceuticals (REGN)
Raytheon Technologies Corp (RTX)
Oracle Corporation (ORCL)
Asml Holding N V N Y Registry Shs (ASML)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Kinder Morgan (KMI)
Palo Alto Networks (PANW)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Amgen (AMGN)
Thermo Fisher Scientific (TMO)

View all positions for Ellerson Group

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Foundations Investment Advisors
LPL Financial
Anfield Capital Management
Jpmorgan Chase & Co
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc
Goldman Sachs Group
Brown Advisory Holdings Incorporated
Accurate Wealth Management
Raymond James Financial
Prevail Innovative Wealth Advisors
Wells Fargo & Company
Concord Investment Counsel
Advisor Group Holdings

View all funds holding iShares Dow Jones US Pharm Indx